Patient Square Capital’s Celcuity CELC Stock Holding History

Patient Square Capital’s Portfolio CELC Stock Details CELC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.8M	Sell	95,000 -25,000	-21%	-$2.73M	1.92%	14
2025 Q4	$12M	Buy	120,000 +20,000	+20%	+$1.64M	2.56%	10
2025 Q3	$4.94M	Buy	+100,000	New	+$4M	1.32%	14

Other funds holding CELC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Patient Square Capital's CELC Position: Q1 2026 in Review

Patient Square Capital reduced its Celcuity (CELC) stake by 21% in Q1 2026, selling an estimated $2.73M and leaving 95,000 shares worth $10.8M. The position accounts for 1.92% of the portfolio, ranked #14.

Patient Square Capital first reported a position in CELC in Q3 2025 and has held it in 3 quarters since. The position peaked at $12M in Q4 2025. 275 funds tracked by Wall St. Rank hold CELC as of Q1 2026.

Patient Square Capital held 95,000 shares of Celcuity worth $10.8M as of Q1 2026.
Patient Square Capital sold 25,000 Celcuity shares in Q1 2026, an estimated $2.73M.
Celcuity made up 1.92% of Patient Square Capital's portfolio in Q1 2026, its #14 holding.
Patient Square Capital first reported a position in Celcuity in Q3 2025 and has held it in 3 quarters since.
Patient Square Capital's Celcuity position peaked at $12M in Q4 2025.
275 funds tracked by Wall St. Rank held Celcuity as of Q1 2026.

Based on Patient Square Capital's 13F filing for Q1 2026, filed 15 May 2026.